WO2001082871A3 - Method of using zinc isotope for therapy and diagnosis of colon cancer - Google Patents

Method of using zinc isotope for therapy and diagnosis of colon cancer Download PDF

Info

Publication number
WO2001082871A3
WO2001082871A3 PCT/US2001/014664 US0114664W WO0182871A3 WO 2001082871 A3 WO2001082871 A3 WO 2001082871A3 US 0114664 W US0114664 W US 0114664W WO 0182871 A3 WO0182871 A3 WO 0182871A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
colon cancer
therapy
zinc isotope
isotope
Prior art date
Application number
PCT/US2001/014664
Other languages
French (fr)
Other versions
WO2001082871A2 (en
Inventor
David Tsai
Original Assignee
Ambryx Biotechnology Inc
David Tsai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambryx Biotechnology Inc, David Tsai filed Critical Ambryx Biotechnology Inc
Publication of WO2001082871A2 publication Critical patent/WO2001082871A2/en
Publication of WO2001082871A3 publication Critical patent/WO2001082871A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi

Abstract

This invention relates generally to treatment and diagnosis of cancer, and more specifically to treatment and diagnosis of colon cancer employing a zinc isotope or a combination of a zinc isotope and a phosphate binder.
PCT/US2001/014664 2000-05-04 2001-05-04 Method of using zinc isotope for therapy and diagnosis of colon cancer WO2001082871A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56691900A 2000-05-04 2000-05-04
US09/566,919 2000-05-04

Publications (2)

Publication Number Publication Date
WO2001082871A2 WO2001082871A2 (en) 2001-11-08
WO2001082871A3 true WO2001082871A3 (en) 2002-02-28

Family

ID=24264957

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/014664 WO2001082871A2 (en) 2000-05-04 2001-05-04 Method of using zinc isotope for therapy and diagnosis of colon cancer

Country Status (1)

Country Link
WO (1) WO2001082871A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072054A1 (en) * 2004-12-30 2006-07-06 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
US10226484B2 (en) 2014-12-01 2019-03-12 Peter Y Novak Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof
WO2018102397A1 (en) 2016-11-29 2018-06-07 PureTech Health LLC Exosomes for delivery of therapeutic agents
US10183041B2 (en) 2017-04-12 2019-01-22 Vector Vitale Ip Llc Antibacterial composition and its use in treating bacterial infections
US11484610B2 (en) 2019-11-22 2022-11-01 Vector Vitale Ip Llc Method of treating melanoma
US11596650B2 (en) 2019-12-20 2023-03-07 Vector Vitale Ip Llc Composition and method for the treatment of type 2 diabetes
US10799530B1 (en) 2019-12-20 2020-10-13 Vector Vitale Ip Llc Composition and method for the prevention and treatment of obesity
US10933091B1 (en) 2019-12-20 2021-03-02 Vector Vitale Ip Llc Composition and method for the treatment of type I diabetes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758421A (en) * 1985-03-15 1988-07-19 The Board Of Trustees Of The Leland Stanford Junior University Bleomycin conjugates and method
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758421A (en) * 1985-03-15 1988-07-19 The Board Of Trustees Of The Leland Stanford Junior University Bleomycin conjugates and method
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore

Also Published As

Publication number Publication date
WO2001082871A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
ZA99693B (en) Compounds for therapy and diagnosis of lung cancer and methods for their use.
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2001279707A1 (en) Diagnosis of behavioural disorders, neurological disorders and cancer
AU2002322280A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
WO2003059251A3 (en) Antibody targeting compounds
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2003300368A8 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
MXPA03003632A (en) Method for treatment of tumors using combination therapy.
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2000018439A3 (en) Use of neoangiogenesis markers for diagnosing and treating tumours by therapy
WO2002077172A3 (en) Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors
AU2002226030A1 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
WO2001082871A3 (en) Method of using zinc isotope for therapy and diagnosis of colon cancer
WO2004033666A3 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HK1041827A1 (en) Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame.
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
MXPA03007036A (en) Method of cancer therapy.
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AP2004003070A0 (en) The method of treating cancer.
WO2003073818A3 (en) Proteomic analysis of tumors for development of consultative report of therapeutic options

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CN JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): CN JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP